BIOA | BioAge LabsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$5.96
+$0.16 (+2.76%)

BioAge Labs (BIOA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and between the two on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $5.96 vs 50 $7.25 / 200 $15.67
Projection
No cross projected
Test
No active test
Last cross
Death cross 3 Sep 2026 ยท projected 25 bars out

Weekly

No weekly data

4-hour as of 3 Nov 13:30 ET

Price
between the two $5.96 vs 50 $5.84 / 200 $12.90
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Cross history

2
crosses on record since 2025
1 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
3 Sep 2026Death steepdaily25 bars outNot tested
24 Sep 2025Golden moderatedaily12 bars outNot tested

About BIOA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.